The Solicitor General's Office has spoken: A rethink of the Supreme Court's Section 101 jurisprudence is "amply warranted."

Just not quite yet.

Solicitor General Noel Francisco and the U.S. Patent and Trademark Office recommended Friday that the court deny certiorari in two hot-button cases in which the Supreme Court sought recommendations last winter: Berkheimer v. HP and Hikma Pharmaceuticals USA v. Vanda Pharmaceuticals. The government says a third case, Athena Diagnostics v. Mayo Collaborative Services, which is due for a cert vote as soon as next month, is a better vehicle for clarifying patent eligibility.